➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Mallinckrodt
Medtronic
Merck
Boehringer Ingelheim

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022404


Email this page to a colleague

« Back to Dashboard

NDA 022404 describes ORAVIG, which is a drug marketed by Galt Pharms and is included in one NDA. There are three patents protecting this drug. Additional details are available on the ORAVIG profile page.

The generic ingredient in ORAVIG is miconazole. There are twenty-eight drug master file entries for this compound. Additional details are available on the miconazole profile page.
Summary for 022404
Tradename:ORAVIG
Applicant:Galt Pharms
Ingredient:miconazole
Patents:3
Formulation / Manufacturing:see details
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 022404
Generic Entry Date for 022404*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;BUCCAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;BUCCALStrength50MG
Approval Date:Apr 16, 2010TE:RLD:Yes
Patent:⤷  Free Forever TrialPatent Expiration:Sep 11, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Patent:⤷  Free Forever TrialPatent Expiration:Sep 11, 2022Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Patent:⤷  Free Forever TrialPatent Expiration:Sep 11, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Mallinckrodt
Boehringer Ingelheim
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.